Why the study?
What are the contemporary patterns of discharge aspirin dosing after acute myocardial infarction in the United States?
What are the contemporary patterns of discharge aspirin dosing after acute myocardial infarction in the United States?
Despite data suggesting similar efficacy and lower bleeding risk with low-dose aspirin, the majority of US patients with MI between 2007 and 2011 were still discharged on high-dose aspirin, even those at high bleeding risk.
No takes yet. Share an insight, caveat, or question.
Discharge aspirin patterns after MI reveal an evidence-practice gap; this Level 3 cohort study leaves open whether low-dose adoption has since improved bleeding safety.
Hall et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: